MASSACHUSETTS GENERAL HOSPITAL
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Supporting Patient Care With Electronic Resources in the United States
Not Applicable
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Behavioral: US-ANSWER-2 decision aidBehavioral: Control group (Online medication guide)
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT02787538
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
GI Complications in Cancer Immunotherapy Patients
- Conditions
- Malignant Melanoma
- First Posted Date
- 2016-05-27
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT02784366
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit
Phase 2
Withdrawn
- Conditions
- Muscle Atrophy
- Interventions
- Dietary Supplement: beta-hydroxy-beta-methylbutyrateDietary Supplement: PlaceboDietary Supplement: Vital HP®
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Massachusetts General Hospital
- Registration Number
- NCT02773771
Development of a Resiliency Training Program for Parents of Children With Specific Learning Disabilities
Not Applicable
Completed
- Conditions
- Stress
- Interventions
- Behavioral: Relaxation Response Resiliency Training for Parents of SPLD
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2019-09-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 53
- Registration Number
- NCT02772432
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Feasibility of mindBEAGLE in Disorders of Consciousness or Locked-In Syndrome
Not Applicable
Completed
- Conditions
- Locked-In SyndromeConsciousness Disorders
- Interventions
- Device: mindBEAGLE EEG-based brain-computer interface
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02772302
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Shared Decision Making for Prescription Opioids After Cesarean Delivery
Not Applicable
Completed
- Conditions
- PregnancyAnalgesics, OpioidPrescriptionsCesarean Section
- Interventions
- Other: Prescribed opioids
- First Posted Date
- 2016-05-12
- Last Posted Date
- 2019-03-07
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT02770612
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Study of Pregnancy Regulation of Insulin and Glucose
Completed
- Conditions
- Gestational Diabetes Mellitus
- Interventions
- Other: Oral glucose tolerance test
- First Posted Date
- 2016-05-05
- Last Posted Date
- 2022-05-10
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 234
- Registration Number
- NCT02763267
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Effect of Head Rotation on Efficiency of Face Mask Ventilation in Anesthetized Apneic Adults
Not Applicable
Completed
- Conditions
- Anesthesia
- Interventions
- Procedure: Head rotation during mask ventilation
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2016-04-28
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02755077
Positive Psychology for ACS Patients: a Factorial Design Study
Not Applicable
Completed
- Conditions
- Acute Coronary Syndrome
- Interventions
- Other: Positive Psychology (PP)Other: Motivational Interviewing (MI)
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT02754895
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
A Study of Capmatinib (INC280) in NSCLC Patients With MET Exon 14 Alterations Who Have Received Prior MET Inhibitor
Phase 2
Completed
- Conditions
- Malignant Non-small Cell Neoplasm of Lung Stage IV
- Interventions
- First Posted Date
- 2016-04-25
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT02750215
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States